20493 ⎘
Medicinal preparations containing organic active ingredients Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEPHROPATHY AND/OR DIABETES MELLITUS, COMPRISING ENAVOGLIFLOZIN
#2RELAXIN ANALOGS AND METHODS OF USING THE SAME
#3AURICULAR VAGAL NERVE STIMULATION TO MITIGATE INFLAMMATORY COMPLICATIONS FOR BIOACTIVE AGENTS
#4METHOD FOR TREATING SUBJECTS SUFFERING FROM CENTRAL NERVOUS SYSTEM CONTUSIONS
#5PHARMACEUTICAL COMPOSITION AND USE THEREOF
#6METHODS AND COMPOSITIONS FOR TREATMENT OF AMYLOID-RELATED DISORDERS
#7COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME
#8LOW-SORBING GLYBURIDE FORMULATION AND METHODS
#9METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA
#10METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA
#11METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA
#12METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA
#13DRUG-IN-CAPSULE FORMULATIONS OF THROMBOXANE RECEPTOR ANTAGONISTS
#14COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#15LOW-SORBING GLYBURIDE FORMULATION AND METHODS
#16AGGREGATE FORMED BY MEANS OF ASSEMBLING CHALCOGEN HETEROCYCLIC COMPOUND AND INSULIN, AND PREPARATION METHOD THEREFOR, AND INSULIN ORAL PREPARATION
#17METHODS OF INTRAVENOUS ADMINISTRATION OF GLYBURIDE
#18CANNABINOID RECEPTOR MODULATING COMPOUNDS
#19LOW-SORBING GLYBURIDE KIT, FORMULATION AND METHODS
#20METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS
#21METHODS OF LOWERING BLOOD GLUCOSE AND TREATING TYPE 2 DIABETES BY ACTIVATION OF PDE4D3
#22TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG
#23COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME
#24METHODS OF TREATING INJURIES OR CONDITIONS RELATED TO CNS EDEMA
#25COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME
#26PHARMACEUTICAL COMPOSITION FOR PREVENTING DIABETES AND USE THEREOF
#27NOVEL SUBSTITUTED SULFONYLUREA COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
#28APPLICATION OF ION CHANNEL BLOCKER IN TREATMENT AND/OR PREVENTION OF HEPATIC FIBROSIS
#29COMBINATION OF A NURR1 AGONIST WITH AT LEAST ONE OF AN ALDOSTERONE ANTAGONIST, AN INSULIN MODULATOR AND A SULFONYLUREA
#30Polymorphic compounds and uses thereof
#31TARGETING SELECT LIPID SIGNALING TO COUNTER TYPE 1 DIABETES (T1D)
#32COMPOUND SERVING AS NLRP3 INHIBITOR
#33COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS
#34LOW-SORBING GLYBURIDE FORMULATION AND METHODS
#35METHODS OF TREATING INJURIES OR CONDITIONS RELATED TO CNS EDEMA
#36TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL ANTIDIABETIC DRUG
#37Methods of Treating Diabetic Cardiomyopathy by Inhibiting GLUT1
#38EP4 INHIBITORS AND USE THEREOF
#39INHIBITION OF miR-29b-3p TO ENHANCE NEURONAL SURVIVAL IN HUNTINGTON'S DISEASE
#40Methods of intravenous administration of glyburide
#41METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#42COMBINATION DRUG FOR THE CONTROL AND MANAGEMENT OF TYPE 2 DIABETES MELLITUS
#43Modulators Of Purinergic Receptors and Related Immune Checkpoint For Treating Acute Respiratory Distress Syndrome
#44Compositions and Methods for the Treatment of Inflammation in Urological Pathology
#45NON-INVASIVE METHOD OF TREATING COVID-19 INFECTION
#46PREVENTING AND TREATING HYPOGLYCEMIA
#47METHODS OF TREATING MULTIPLE SCLEROSIS
#48COMPOSITIONS AND METHODS FOR TREATING LUNG INJURY
#49N-PHENYL-3-MERCAPTOPROPANAMIDE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS
#50METHOD FOR THE TREATMENT NLRP3-ASSOCIATED DISEASES
#51PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABETES AND METABOLIC DISEASES ASSOCIATED THEREWITH
#52COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#53METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS INFECTION
#54METHODS OF TREATING MULTIPLE SCLEROSIS
#55NOVEL SUBTITUTED SULFONYLUREA AND SULFOXIMINEUREA DERIVATIVES
#56COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#57METHODS AND COMPOSITIONS PRODUCED THEREBY
#58INSULIN ANALOGS AND METHODS OF USING THE SAME
#59METHODS OF DEFINING FUNCTIONAL CHANGE AND SLOWING PROGRESSION IN CHRONIC LIVER DISEASE
#60METHODS OF TREATING OR SELECTING A TREATMENT FOR A SUBJECT RESISTANT TO TNF INHIBITOR USING A NLRP3 ANTAGONIST
#61COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#62Herbal composition for metabolic syndromes and method of treatment thereof
#63COMBINATION PRODUCT CONTAINING LIMONOID COMPOUND AND SULFONYLUREA COMPOUND
#64LOW-SORBING GLYBURIDE FORMULATION AND METHODS
#65METHODS OF TREATING BILE ACID DIARRHEA
#66RELAXIN ANALOGS AND METHODS OF USING THE SAME
#67SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSM
#68METHODS FOR DETERMINING RISK OF DEVELOPING INSULIN RESISTANCE
#69COMBINATION
#70Enhancing drug activity through accentuated buccal/sublingual administration.
#71METHODS AND USES FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES
#72METHOD FOR TREATING SUBJECTS SUFFERING FROM CENTRAL NERVOUS SYSTEM CONTUSIONS
#73INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY
#74ALLOSTERIC AGONISTS AND POSITIVE ALLOSTERIC MODULATORS OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR
#75LOW-DOSE TRIPLE COMBINATION FORMULATION
#76MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF
#77NANOPARTICLE MEDIATED THERAPY
#78METHOD FOR PRODUCING ORAL DISINTEGRATING FILM COMPRISING POORLY SOLUBLE DRUG
#79Methods of treating injuries or conditions related to CNS edema
#80METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#81Compositions of grapiprant and methods for using the same
#82METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS
#83Method for reducing fat by administering benzenesulfonamide compositions
#84PHARMACEUTICAL COMPOSITIONS OF TORSEMIDE AND USES THEREOF
#85USE OF CANNABANOIDS IN THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
#86Liquid formulations of hypoglycaemic sulfonamides
#87CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATOR RELACORILANT AND CYP2C9 SUBSTRATES
#88GRAPIPRANT UNIT DOSAGE FORMS
#89PROCESS FOR PREPARATION OF GRAPIPRANT
#90BIOACTIVE VITAMIN COMBINATIONS
#91POLYMORPHIC COMPOUNDS AND USES THEREOF
#92Fluorinated bile acid derivatives
#93Biomaterial and method for promoting tissue regeneration by using the biomaterial
#94EP4 INHIBITORS AND USE THEREOF
#9517beta-heterocyclyl-digitalis like compounds for the treatment of heart failure
#96METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID-RELATED DISORDERS
#97FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
#98METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES
#99METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING METABOLIC SYNDROME INDUCED BY ANTIPSYCHOTIC TREATMENT AND RELATED DISEASES AND CONDITIONS
#100Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
#101Methods of intravenous administration of glyburide
#102Glucagon receptor antagonists
#103Targeting NCchannel for organ protection following ischemic episode
#104COMPOSITION CONTAINING GLIBENCLAMIDE
#105Process for preparation of grapiprant
#106Method of treating or preventing neurodegeneration
#107COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HYPERGLYCEMIA, INSULIN RESISTANCE, AND ASSOCIATED ORGAN DAMAGE
#108THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS
#109METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#110COMPOSITIONS AND METHODS FOR TREATING PAIN
#111Compositions and methods for the treatment of inflammation in urological pathology
#112METHOD OF TREATING A METABOLIC DISORDER OF THE LIVER
#113HEALTH CARE
#114METHOD OF USING A LIGHT-BASED DRUG DISPENSING SYSTEM TO SIMULATE THE OPERATION OF A HUMAN PANCREAS
#115Herbal composition for metabolic syndromes and method of treatment thereof
#116INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION
#117Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
#118SULFONYLUREA COMPOUNDS IN THE TREATMENT OF DISEASE ASSOCIATED WITH UV-INDUCED DAMAGE
#119THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF
#120TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL ANTIDIABETIC DRUG
#121COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ADRENOCORTICAL ACTIVITY AND/OR EXCESSIVE STEROID PRODUCTION
#122Composition containing glibenclamide
#123Formulations and methods for lyophilization and lyophilates provided thereby
#124Acylated glucagon analogue
#125Pharmaceutical composition comprising a sulfonylurea drug and preparation method thereof
#126USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATED LIVER CANCER
#127Thromboxane receptor antagonists
#128Methods of intravenous administration of glyburide
#129VAP polypeptide and use thereof in preparation of drug for targeted diagnosis and treatment of tumor
#130EP4 inhibitors and use thereof
#131Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer
#132Methods of medical treatment with SUR1-TRPM4 channel inhibitors
#133Compositions for treating amyotrophic lateral sclerosis
#134METHODS OF TREATING OR PREVENTING AMYLOID RELATED IMAGING ABNORMALITIES ASSOCIATED WITH ALZHEIMER'S DISEASE TREATMENT
#135Formulations and methods for lyophilization and lyophilates provided thereby
#136Combinations of LSD1 inhibitors for the treatment of hematological malignancies
#137Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production
#138Compositions for treating amyotrophic lateral sclerosis
#139Compositions for treating neurological disorders
#140Synergistic compositions
#141METHOD OF MAKING DIALKYL SULFOSUCCINATE COMPOSITIONS
#142Composition containing glibenclamide
#143THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
#144METHOD OF USING A LIGHT-BASED DRUG DISPENSING SYSTEM TO SIMULATE THE OPERATION OF A HUMAN PANCREAS
#145Veterinary composition comprising torasemide for the treatment of pulmonary edema associated with heart failure in domestic animals
#146Glucagon-like peptide 1 modulator and uses thereof
#147Thromboxane receptor antagonists
#148METHODS FOR TREATING NEURAL CELL SWELLING
#149Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells
#150Nitrite salts of 1,1-dimethylbiguanide, pharmaceutical compositions, and methods of use
#151COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
#152Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer
#153Acylated glucagon analogue
#154Fumagillol derivatives
#155Inflammasome activation in myelodysplastic syndromes
#156COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#157PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS
#158Methods of intravenous administration of glyburide
#159INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY
#160Methods of intravenous administration of glyburide
#161Synergistic compositions
#162Pharmaceuticals for Oral Delivery
#163Methods for treating central or peripheral nervous system damage
#164Isoxazole derivatives as FXR agonists and methods of use thereof
#165PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN
#166Liquid formulations of compounds active at sulfonylurea receptors
#167Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
#168Compositions and related methods for treating and preventing viral and retroviral infections
#169Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
#170NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING
#171Pharmaceuticals for oral delivery
#172LIGHT-BASED DRUG DISPENSING SYSTEM TO SIMULATE THE OPERATION OF A HUMAN PANCREAS
#173COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME
#174Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
#175Dialkyl sulfosuccinate compositions, method of making, and method of use
#176Modulators of intracellular chloride concentration for treating down syndrome
#177Methods and compositions for treating nephrogenic diabetes insipidus
#178Controlled-release formulations comprising Torsemide
#179Methods of treating and preventing diseases and disorders of the central nervous system
#180Composition comprising torasemide and baclofen for treating neurological disorders
#181Compositions and methods for efficacious and safe delivery of siRNA using specific chitosan-based nanocomplexes
#182Compositions for treating amyotrophic lateral sclerosis
#183Synergistic compositions
#184Modulation of cellular DNA repair activity to intercept malignancy
#185Methods of intravenous administration of glyburide
#186Thromboxane receptor antagonists
#187Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#188Compositions of grapiprant and methods for using the same
#189Medical use of a DPP-4 inhibitor
#190Methods of intravenous administration of glyburide
#191Co-Therapy for Diabetic Conditions
#192Formulations and methods for lyophilization and lyophilates provided thereby
#193Liquid formulations of hypoglycaemic sulfonamides
#194Compounds that modulate autoimmunity and methods of using the same
#195Crystalline form of sitagliptin sulfate
#196Methods of treating and preventing diseases and disorders of the central nervous system
#197PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
#198Methods and compositions for treating nephrogenic diabetes insipidus
#199Therapeutic approaches for treating Alzheimer's disease
#200METHODS FOR TREATING OR PREVENTING FIBROSIS IN SUBJECTS AFFLICTED WITH SCLERODERMA
#201Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules
#202Synergistic anti-diabetic compositions
#203Pharmaceuticals for oral delivery
#204Methods for treating neural cell swelling
#205Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity
#206SODIUM CHANNEL BLOCKERS REDUCE GLUCAGON SECRETION
#207Method for the treatment of acne by administering IL-1β antibody
#208Inhibitors of NCchannels for therapy
#209Treatment of cerebral ischemia
#210Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA activated ATP-sensitive cation channels regulated by SUR1 channels
#211KATP antagonists (glibenglamid) for use for promoting growth and/or treating hyperglycaemia of a premature infant
#212Compositions for treating neurological disorders
#213Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#214Co-Therapy for Diabetic Conditions
#215Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
#216METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING MUSCLE MYOPATHY DISORDERS
#217Formulations and methods for lyophilization and lyophilates provided thereby
#218METHODS FOR ADMINISTERING HYPOGLYCEMIC AGENTS
#219Methods of intravenous administration of glyburide and other drugs
#220PHARMACEUTICAL COMPOSITION AND DOSAGE FORMS OF ELINOGREL AND METHODS OF USE THEREOF
#221Baclofen and acamprosate based therapy of neurological disorders
#222Method of treating type II diabetes, hyperglycemia or hypoglycemia by administering a synergistic combination of a sulphonylurea and inulin
#223Co-Therapy for Diabetic Conditions
#224PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS
#225METHODS FOR TREATING NEURAL CELL SWELLING
#226RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNIT
#227Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
#228METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF GLUCOSE HOMEOSTASIS
#229Lipidomic Biomarkers of Diabetes
#230USE OF A DPP-IV INHIBITOR TO REDUCE HYPOGLYCEMIC EVENTS
#231Method for the production of bioadhesive compact matrices
#232PHARMACEUTICAL COMPOSITIONS OF ACTIVE PHARMACEUTICAL INGREDIENT COMPRISING SULPHONYLUREA MOIETY WITH EXCELLENT DISSOLUTION PROPERTIES
#233Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis
#234PHARMACEUTICAL COMPOSITIONS
#235Coated drug delivery formulations
#236SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY
#237Radioprotective agents
#238COMPOSITIONS OF PROTON PUMP INHIBITORS AND INSULIN SECRETAGOGUES, AND METHODS OF THEIR USE TO TREAT DIABETES
#239COMPOSITIONS OF PROTON PUMP INHIBITORS, KITS AND METHODS OF THEIR USE TO TREAT DIABETES
#240SPACED DRUG DELIVERY SYSTEM
#241Pharmaceutical compositions for the treatment of diabetes mellitus
#242AGENT FOR TREATMENT OF DIABETES
#243Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients
#244Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel
#245LIQUID FORMULATIONS OF COMPOUNDS ACTIVE AT SULFONYLUREA RECEPTORS
#246Pharmaceutical composition
#247MODULATING BODY WEIGHT
#248Inhibitors of NCchannels for therapy
#249PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS
#250Formulations and methods for lyophilization and lyophilates provided thereby
#251Co-Therapy For Diabetic Conditions
#252Combination of triazine derivatives and insulin secretion stimulators
#253TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES
#254Medicine for treating gastrointestinal disorder including fecal incontinence
#255PHARMACEUTICAL COMPOSITIONS OF POORLY SOLUBLE DRUGS
#256COMPOSITION COMPRISING A DIURETIC AND A CARDIAC GLYCOSIDE FOR THE TREATMENT OF DNA VIRAL INFECTIONS OF THE EYE
#257Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate
#258Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
#259Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes
#260Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes
#261Triazole compounds and uses related thereto
#262Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
#263Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
#264Treatment of Melanoma With Alpha Thymosin Peptides
#2655 HT RECEPTOR MEDIATED NEUROGENESIS
#266Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof
#2675 HT RECEPTOR MEDIATED NEUROGENESIS
#268Compositions comprising balaglitazone and further antidiabetic compounds
#269Compositions and methods for treating diabetes and neuropsychological dysfunction
#270Treatment of Barrett's Esophagus
#271Type-2 Diabetes Combination Wafer
#272Pharmaceutical composition
#273Dividable galenical form allowing modified release of the active ingredient
#274NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING
#275Combination therapy
#276Therapeutic methods that target the NCchannel
#277GLP-1 AND METHODS FOR TREATING DIABETES
#278Concomitant pharmaceutical agents and use thereof
#279Novel Combinational Use of Sulfonamide Compound
#280Antisense Modulation of PTP1B Expression
#281Solid preparation
#282COMBINED PREPARATION OF A THIAZIDE DIURETIC AND A LOOP DIURETIC
#283Treatment of Diabetes and Related Pathologies
#284Use of DPP-IV inhibitor to reduce hypoglycemic events
#285Treatment of Melanoma with Alpha Thymosin Peptides
#286Compositions and Methods Relating to Mitochondrial Hyperpolarization in Neurological Disease
#287COMPOSITION CONTAINING A THIOUREA DERIVATIVE FOR PREVENTING OR TREATING PRURITIC OR IRRITANT SKIN DISEASES
#288Methods for administering hypoglycemic agents
#289Triazole compounds and uses related thereto
#290Prolonged-Release Compositions Comprising Torasemide and a Matrix-Forming Polymer
#291Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer
#292Methods for treating neural cell swelling
#293Finely divided composition containing poorly water soluble substance
#294TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE AND SULPHONYLUREA
#295PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE OF AN INSULIN SENSITISER AND ANOTHER ANTIDIABETIC AGENT
#296Cholesterol transport gene
#297METHOD OF TREATING METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES
#298Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
#299USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA
#3005 HT receptor mediated neurogenesis